Anterra Capital Raises $100M to Bet on AI-Native Biotech and Software in Food and Agriculture

Managing Partner Adam Anders has pointed to a reset in agtech valuations as a key motivation. The firm argues that valuations have returned to 2016 levels, creating what it calls the "most attractive deployment moment in twelve years" . This thesis is paired with an insistence that AI is not just an efficiency layer but a transformative force — vertical AI platforms are digitizing core operations in food distribution, while AI-driven biology is accelerating R&D cycles and reducing capital requirements for new biological approaches .

Who is backing the new fund

The investor base for Fund III reads as a who's-who of the food system. Anchor limited partners include Rabobank, Novo Holdings, and Zoetis, alongside other institutional LPs and operators who collectively farm more than 13 million acres . The continued backing from longstanding strategic investors signals institutional conviction in the sector's technology transition even as broader venture funding retreats.

Early deployments signal the AI focus

Fund III has already made two investments that illustrate its thesis in practice:

• Anchr — an AI-native platform modernizing the back office of food distribution, a trillion-dollar industry still running largely on paper. The investment was made alongside a16z Speedrun .
• Animerra — a veterinary biologics company founded and built by Anterra itself, applying proven biological approaches to animal health and advancing its science with a lean team at a pace that would not have been possible five years ago. Cavallo Ventures co-invested .

Both deals reflect the fund's conviction that AI is enabling startup-scale companies to tackle problems that previously required far larger organizations and longer timelines.

Market context: swimming against the tide

The first close comes during a pronounced contraction in global agtech investment. From a peak of roughly $52 billion in 2021, annual investment in the sector has fallen to an estimated $16 billion . Against that backdrop, Anterra's raise is a notable counter-trend signal — and a test of whether AI-native companies can deliver returns in a sector where many generalist investors have pulled back. With Fund III, Anterra will have managed more than $500 million in total commitments since inception . Its previous fund closed at $260 million in 2022 .

Firm track record and what comes next

Anterra has been investing across the food and agriculture value chain for over a decade, with a portfolio that has included companies like Enko (novel small-molecule crop protection), ProducePay (financial and data services for fresh produce), and BiomEdit (microbiome innovation for animal health) . The firm typically invests at Seed or Series A with initial checks of $1 million to $15 million .

With Fund III's final close targeted later this year, the firm is positioning itself at the intersection of two powerful forces: a cyclical valuation reset that may favor disciplined specialist investors, and a structural technology shift that the firm believes is still in its early innings across food and agriculture.

This article draws on reporting published June 15–16, 2026, and will be updated as further details on Fund III's progress become available.